Skip to content ↓

Jury finds MIT not liable in brain tumor trial

A Boston jury today reached a verdict in the case of Heinrich et al v. Sweet et al, in the US District Court of the District of Massachusetts, involving a suit by surviving family members of patients with a fatal brain tumor who underwent experimental treatments performed by Dr. William Sweet and his Massachusetts General Hospital colleagues at the MIT nuclear research reactor in the 1960s.

The following is the statement issued by the Massachusetts Institute of Technology through spokesman Kenneth D. Campbell:

The Massachusetts Institute of Technology is pleased that the jury upheld MIT's position that it acted appropriately.

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story